Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 1 month ago Source:  Transcatheter Academy
An individual patient data (IPD) meta-analysis has found that using fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) is associated with a significant reduction in major adverse events compared to a standard angiography-guided strategy. The benefit appears to be driven primarily by a reduction in peri-procedural myocardial infarction (MI).¹The PRIME Collaboration… View more
Author(s): Suzanne J Baron Added: 1 month ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible… View more
Author(s): Byeong-Keuk Kim Added: 1 year ago
ESC Congress 24 — OCCUPI trial finds OCT-guided PCI more effective than angiography-guided PCI in reducing heart-related events.We are joined onsite at ESC 24 by Dr Kim Byeoung-Keuk (Yonsei University College of Medicine, Seoul, SK) to discuss the results of the OCCUPI trial (NCT03625908), which aims to evaluate the clinical benefits of optical coherence tomography (OCT)-guided percutaneous… View more
Author(s): Steven Keller Added: 1 year ago
Added: 1 week ago Source:  Radcliffe Cardiology
The first month following primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is a period of high risk for major adverse cardiovascular events (MACEs). The TADCLOT trial aimed to compare the efficacy of ticagrelor against a twice-daily clopidogrel regimen in this critical short-term window.¹The TADCLOT (Twice-A-Day CLOpidogrel vs Ticagrelor)… View more
Author(s): Added: 9 months ago
TIMELY is an integrated AI-based healthcare solution consisting of a certified physician platform and a patient app. It has been developed within an EU-funded project running from 2021 to 2025. TIMELY aims to assist both cardiac patients and their clinicians in personalising healthcare by evaluating risks and offering individualised exercise recommendations. The solution has been evaluated within… View more